Patent · US Expired

Compound for treatment of allergy and asthma

US6986889B2 · kind B2 · utility

3Cited by

4References

15Claims

0Family size

Assignee

Pharmacia Diagnostics AB · SE

Inventors

Sylvia Laffer · Wien, AT
Erik Hogbom · Uppsala, SE
Kenneth H. Roux · Tallahassee, US
Jonas Adriansson · Uppsala, SE
Wolfgang Sperr · Wien, AT
Peter Valent · Wien, AT
Dietrich Kraft · Wien, AT
Hans Grönlund · Lidingö, SE
Rudolf Valenta · Theresienfeld, AT

Key dates

Filing date	Mar 28, 2002
Grant date	Jan 17, 2006
Priority date	—
Expiry date	Nov 19, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a novel drug candidate having a potential for universal therapy of allergy and asthma.The invention provides a Fab (antibody fragment), having the following characteristics:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.